Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

SAB1305546

Sigma-Aldrich

Anti-β-Actin (ACTB) Antibody

mouse monoclonal, 8H10D10

Synonym(e):

ACTB, Actin, cytoplasmic 1, Actin, cytoplasmic 1, N-terminally processed, Beta-actin

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

400 μL
CHF 461.00

CHF 461.00

Voraussichtliches Versanddatum02. April 2025

Alle Fotos(1)

Größe auswählen

Ansicht ändern
400 μL
CHF 461.00

About This Item

UNSPSC-Code:
12352203
NACRES:
NA.41

CHF 461.00

Voraussichtliches Versanddatum02. April 2025

Produktbezeichnung

MONOCLONAL ANTI-BETA-ACTIN antibody produced in mouse, clone 8H10D10, IgG fraction of antiserum, buffered aqueous solution

Biologische Quelle

mouse

Qualitätsniveau

100

Antikörperform

IgG fraction of antiserum

Antikörper-Produkttyp

primary antibodies

Klon

8H10D10, monoclonal

Form

buffered aqueous solution

Mol-Gew.

41737 Da

Speziesreaktivität

human

Methode(n)

immunohistochemistry: 1:10-1:50
western blot: 1:2000-1:10000

NCBI-Hinterlegungsnummer

NP_001092.1

UniProt-Hinterlegungsnummer

P60709

Versandbedingung

wet ice

Lagertemp.

−20°C

Posttranslationale Modifikation Target

unmodified

Angaben zum Gen

human ... ACTB(60)

Verwandte Kategorien

Anwendung

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Western Blotting (1 paper)

Physikalische Form

Supplied in PBS with 0.09% (W/V) sodium azide

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

10 - Combustible liquids

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
SG100521A

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Breanna Cole-Skinner et al.
Frontiers in cell and developmental biology, 12, 1348707-1348707 (2024-08-05)
Background: Cancer cell evasion of the immune response is critical to cancer development and metastases. Clinicians' ability to kickstart the immune system to target these rogue cells is an ever-growing area of research and medicine. This study delved into the
Angelo Di Vincenzo et al.
Diabetes, metabolic syndrome and obesity : targets and therapy, 16, 1885-1893 (2023-06-29)
Psoriasis is a chronic systemic inflammatory disease involving the production of many pro-inflammatory cytokines derived from immune cells and interacting with different tissues leading to the typical skin lesions. Psoriasis shows a higher prevalence and a worse progression in obese
Yichen Zhao et al.
Cell death & disease, 15(6), 399-399 (2024-06-08)
The loss of dopaminergic neurons in the substantia nigra is a hallmark of pathology in Parkinson's disease (PD). Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) is the critical enzyme responsible for the degradation of asymmetric dimethylarginine (ADMA) which inhibits nitric oxide (NO) synthase and
Alicia Arredondo Eve et al.
Nutrients, 12(9) (2020-08-23)
Diet and lifestyle choices contribute to obesity and liver disease. Broccoli, a brassica vegetable, may mitigate negative effects of both diet and lifestyle. Currently, there are no clinically relevant, established molecular biomarkers that reflect variability in human absorption of brassica
Eylem Kulkoyluoglu-Cotul et al.
Cancers, 11(4) (2019-04-17)
A majority of breast cancer specific deaths in women with ERα (+) tumors occur due to metastases that are resistant to endocrine therapy. There is a critical need for novel therapeutic approaches to resensitize recurrent ERα (+) tumors to endocrine
Alle zugehörigen Dokumente anzeigen

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.